SCHEMBL5309674

SCHEMBL5309674

Nc1nc(-c2ncc[nH]2)ccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.44
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
GSK3A P49840 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
TXNRD1 Q16881 1/20 0.40
CLK1 P49759 2/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
HSP90AA1 P07900 1/20 0.35
AGTR1 P30556 1/20 0.35
RAB9A P51151 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5312641 0.76 NISCH (0.41) ALDH1A1MEN1KMT2APDE3BPDE3A
SCHEMBL5960705 0.73 TDP1 (0.47) GSK3BCCNB2CDK1CCNB1GSK3A
SCHEMBL3790681 0.73 DYRK1A (0.53) GSK3BCLK1CDK5CDK5R1ALDH1A1
SCHEMBL3789449 0.72 MAP2K3 (0.44) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL9110917 0.72 CLK1 (0.37) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL11236516 0.71 MAP4K4 (0.51) GSK3BCLK1CDK5CDK5R1ALDH1A1
SCHEMBL11364760 0.71 ADRA2A (0.38) GSK3BCCNB2CDK1CCNB1GSK3A
SCHEMBL11366986 0.71 ADRA2A (0.38) GSK3BCCNB2CDK1CCNB1GSK3A
SCHEMBL11370414 0.71 ADRA2A (0.38) GSK3BCCNB2CDK1CCNB1GSK3A
SCHEMBL4858552 0.71 KMT2A (0.48) GSK3BALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007045096-A1 OLIGOHETEROAROMATIC LUMINISCENT ASSEMBLIES AS HIGH-AFFINITY DNA SEQUENCE-DIRECTED LIGANDS UNIVERSITY OF SASKATCHEWAN (CA) 2007-04-26 WO disclosed
EP-0556393-B1 FUSED PYRAZINE DERIVATIVE YAMANOUCHI PHARMA CO LTD (JP) 2000-07-26 EP disclosed
US-5283244-A Anticonvulsants, nervous system disorders YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-02-01 US disclosed
EP-0556393-A1 FUSED PYRAZINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1993-08-25 EP disclosed